Education
About Us
Working with TipRanks
Follow Us
C4 Therapeutics (CCCC)
NASDAQ:CCCC
See the Price Targets and Ratings of:
CCCC Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$1.5
Hold
-2.60%
Downside
Reiterated
06/04/25
The overall stock score for C4 Therapeutics is primarily impacted by its financial struggles, highlighted by ongoing losses and negative cash flows. Technical analysis indicates limited momentum, and valuation metrics are unattractive due to a negative P/E ratio. These factors collectively result in a low stock score, suggesting caution for potential investors.
Stifel Nicolaus
$14→$12
Buy
679.22%
Upside
Reiterated
02/28/25
BMO Capital
$20
Buy
1198.70%
Upside
Reiterated
02/27/25
Wells Fargo
$12
Buy
679.22%
Upside
Reiterated
02/27/25
Brookline Capital Markets
$39→$50
Buy
3146.75%
Upside
Reiterated
01/06/25
Morgan Stanley
―
Hold
―
Reiterated
12/09/24
Unknown AnalystEvercore ISI
Not Ranked
Evercore ISI
$10
Buy
549.35%
Upside
Assigned
12/09/24
Stephens
$4
Hold
159.74%
Upside
Initiated
11/18/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$1.5
Hold
-2.60%
Downside
Reiterated
06/04/25
The overall stock score for C4 Therapeutics is primarily impacted by its financial struggles, highlighted by ongoing losses and negative cash flows. Technical analysis indicates limited momentum, and valuation metrics are unattractive due to a negative P/E ratio. These factors collectively result in a low stock score, suggesting caution for potential investors.
Stifel Nicolaus
$14→$12
Buy
679.22%
Upside
Reiterated
02/28/25
BMO Capital
$20
Buy
1198.70%
Upside
Reiterated
02/27/25
Wells Fargo
$12
Buy
679.22%
Upside
Reiterated
02/27/25
Brookline Capital Markets
$39→$50
Buy
3146.75%
Upside
Reiterated
01/06/25
Morgan Stanley
―
Hold
―
Reiterated
12/09/24
Unknown AnalystEvercore ISI
Not Ranked
Evercore ISI
$10
Buy
549.35%
Upside
Assigned
12/09/24
Stephens
$4
Hold
159.74%
Upside
Initiated
11/18/24
Best Analysts Covering C4 Therapeutics
1 Month
xxx
Success Rate
4/11 ratings generated profit
Average Return
-3.69%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 36.36% of your transactions generating a profit, with an average return of -3.69% per trade.
3 Months
xxx
Success Rate
6/17 ratings generated profit
Average Return
+20.26%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.29% of your transactions generating a profit, with an average return of +20.26% per trade.
1 Year
Success Rate
4/17 ratings generated profit
Average Return
-19.25%
reiterated a buy rating 3 months ago
Copying Etzer Darout's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of -19.25% per trade.
2 Years
xxx
Success Rate
1/17 ratings generated profit
Average Return
-47.24%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 5.88% of your transactions generating a profit, with an average return of -47.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CCCC Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Strong Buy
7
7
7
4
3
Buy
0
0
0
0
0
Hold
3
3
1
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
10
8
5
5
Each month's total comprises the sum of three months' worth of ratings.
CCCC Stock Forecast FAQ
What is CCCC’s average 12-month price target, according to analysts?
Based on analyst ratings, C4 Therapeutics’s 12-month average price target is 3.50.
What is CCCC’s upside potential, based on the analysts’ average price target?
C4 Therapeutics has 127.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CCCC a Buy, Sell or Hold?
C4 Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is C4 Therapeutics’s price target?
The average price target for C4 Therapeutics is 3.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.50 ,the lowest forecast is $3.50. The average price target represents 127.27% Increase from the current price of $1.54.
The highest analyst price target is $3.50 ,the lowest forecast is $3.50. The average price target represents 127.27% Increase from the current price of $1.54.
What do analysts say about C4 Therapeutics?
C4 Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of CCCC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.